Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

Presentation THT 2025

Weight Loss Improves Outcome in HFpEF: Summarizing the Clinical Evidence

Presenter: Marco Metra

February 12, 2025

Presentation THT 2025

Is There a Role for Obesity in the Progression of Heart Failure With a Reduced Ejection Fraction?

Presenter: Javed Butler

February 12, 2025

Presentation THT 2025

Inflammation as a Target in Acute HF

Presenter: Gad Cotter

February 12, 2025

Presentation THT 2025

Inflammation and HFpEF: Rationale for HERMES

Presenter: Mark Petrie

February 12, 2025

Presentation THT 2025

How Does Weight Loss Improve Hemodynamics in Patients With HFpEF

Presenter: Barry Borlaug

February 12, 2025

Presentation THT 2025

From Obesity to Inflammation: Common Pathways and New Opportunities in HF

Presenter: Milton Packer

February 12, 2025

Presentation THT 2025

Impact of Obesity Severity on the Effects of Tirzepatide in HFpEF: The SUMMIT Trial

Presenter: Barry Borlaug

February 11, 2025

Presentation THT 2025

Obesity: Assessing the Weight of the Evidence

Presenter: Milton Packer

February 11, 2025

Presentation THT 2025

Impact of Obesity on Clinical Outcomes of Cardiogenic Shock Patients Treated With Advanced Mechanical Circulatory Support

Presenter: Abduljabar Adi

February 11, 2025

Presentation THT 2025

Obesity, Insulin Resistance, and Cardiovascular Disease: The Link between Metabolism and Inflammation

Presenter: Carolyn Lam

February 11, 2025

Presentation THT 2025

Inflammation and Heart Failure: Pathophysiology and Clinical Implications

Presenter: Marat Fudim

February 11, 2025

Presentation THT 2025

Emerging Therapies Targeting Inflammation and Metabolic Dysfunction in Heart Failure

Presenter: Mark Petrie

February 11, 2025

Presentation THT 2025

Case Discussion and Panel Q&A: Multidisciplinary Approaches to Managing Inflammation and Obesity in CVD

Presenter: Josephine Harrington

February 11, 2025

Presentation THT 2025

Obese HFpEF Patients Exhibit Distinct Augmentation Patterns of VO2 Components During Exercise

Presenter: Takenori Ikoma

February 11, 2025

Presentation THT 2024

Mechanisms and Therapeutic Targets for Obesity-Related HFpEF

Presenter: Jennifer Ho

March 04, 2024

Presentation THT 2024

The OBESITY-HF Connection: Time to Attack This Head-on

Presenter: Barry Borlaug

March 04, 2024

Presentation THT 2023

Does Obesity Paradox Exist in Cardiogenic Shock?

Presenter: Maya Guglin

March 22, 2023

Presentation THT 2023

Obesity in Heart Failure with Preserved Ejection Fraction: Insights from the REDUCE LAP-HF II Trial

Presenter: Sheldon Litwin

March 21, 2023

Presentation THT 2023

Clinical Outcomes for Patients with Obesity and High output heart failure: An Analysis of the National Inpatient Sample

Presenter: Rafail Beshai

March 20, 2023

Advertisement

Weight Loss Improves Outcome in HFpEF: Summarizing the Clinical Evidence

Is There a Role for Obesity in the Progression of Heart Failure With a Reduced Ejection Fraction?

Inflammation as a Target in Acute HF

Inflammation and HFpEF: Rationale for HERMES

How Does Weight Loss Improve Hemodynamics in Patients With HFpEF

From Obesity to Inflammation: Common Pathways and New Opportunities in HF

Impact of Obesity Severity on the Effects of Tirzepatide in HFpEF: The SUMMIT Trial

Obesity: Assessing the Weight of the Evidence

Impact of Obesity on Clinical Outcomes of Cardiogenic Shock Patients Treated With Advanced Mechanical Circulatory Support

Obesity, Insulin Resistance, and Cardiovascular Disease: The Link between Metabolism and Inflammation

Inflammation and Heart Failure: Pathophysiology and Clinical Implications

Emerging Therapies Targeting Inflammation and Metabolic Dysfunction in Heart Failure

Case Discussion and Panel Q&A: Multidisciplinary Approaches to Managing Inflammation and Obesity in CVD

Obese HFpEF Patients Exhibit Distinct Augmentation Patterns of VO2 Components During Exercise

Mechanisms and Therapeutic Targets for Obesity-Related HFpEF

The OBESITY-HF Connection: Time to Attack This Head-on

Does Obesity Paradox Exist in Cardiogenic Shock?

Obesity in Heart Failure with Preserved Ejection Fraction: Insights from the REDUCE LAP-HF II Trial

Clinical Outcomes for Patients with Obesity and High output heart failure: An Analysis of the National Inpatient Sample

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content